180 related articles for article (PubMed ID: 22826959)
1. [Construction and application of a noval gene-target therapy system in hepatocellular carcinoma].
Zhang G; Liu T; Wang Z
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Jun; 29(3):563-7, 592. PubMed ID: 22826959
[TBL] [Abstract][Full Text] [Related]
2. Impact of Co-transfection with Livin and survivin shRNA expression vectors on biological behavior of HepG2 cells.
Xu W; Chang H; Qin CK; Zhai YP
Asian Pac J Cancer Prev; 2013; 14(9):5467-72. PubMed ID: 24175843
[TBL] [Abstract][Full Text] [Related]
3. Suicide gene therapy for hepatocellular carcinoma cells by survivin promoter-driven expression of the herpes simplex virus thymidine kinase gene.
Qu L; Wang Y; Gong L; Zhu J; Gong R; Si J
Oncol Rep; 2013 Apr; 29(4):1435-40. PubMed ID: 23354806
[TBL] [Abstract][Full Text] [Related]
4. Effect of recombinant plasmid pEGFP-AFP-hTNF on liver cancer cells (HepG2 Cells) in vitro when delivered by PEG-PEI/Fe₃O₄ nanomagnetic fluid.
Zhuang B; Zhang Y; Peng J; Zhang H; Hu T; Zeng J; Li Y
J Formos Med Assoc; 2011 May; 110(5):326-35. PubMed ID: 21621154
[TBL] [Abstract][Full Text] [Related]
5. Effects of AFP gene silencing on Survivin mRNA expression inhibition in HepG2 cells.
Fang ZL; Fang N; Han XN; Huang G; Fu XJ; Xie GS; Wang NR; Xiong JP
Genet Mol Res; 2015 Apr; 14(2):3184-90. PubMed ID: 25966084
[TBL] [Abstract][Full Text] [Related]
6. Suppression of hepatoma tumor growth by systemic administration of the phytotoxin gelonin driven by the survivin promoter.
Wang Z; Zhou X; Li J; Liu X; Chen Z; Shen G; Guan T; Ye N; Wei X; Huang N; Yang L; Wei Y; Li J
Neoplasma; 2013; 60(5):469-79. PubMed ID: 23790164
[TBL] [Abstract][Full Text] [Related]
7. siRNA targeting survivin inhibits the growth and enhances the chemosensitivity of hepatocellular carcinoma cells.
Liu W; Zhu F; Jiang Y; Sun D; Yang B; Yan H
Oncol Rep; 2013 Mar; 29(3):1183-8. PubMed ID: 23254641
[TBL] [Abstract][Full Text] [Related]
8. Anti-angiogenesis and anticancer effects of a plasmid expressing both ENDO-VEGI151 and small interfering RNA against survivin.
Li Z; Yang S; Chang T; Cao X; Shi L; Fang G
Int J Mol Med; 2012 Mar; 29(3):485-90. PubMed ID: 22109572
[TBL] [Abstract][Full Text] [Related]
9. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
[TBL] [Abstract][Full Text] [Related]
10. [RNA interference-mediated inhibition of survivin expression in Hela cell line by siRNA expression vector targeting survivin gene].
Jiang HC; Sun QM; Zhao D; Sun MS; Lü L; Li HJ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1806-11. PubMed ID: 17259126
[TBL] [Abstract][Full Text] [Related]
11. [Recombinant plasmid pEGFP-AFP-TK delivered by nano-magnetic fluids targeting killed AFP positive HepG2 cells in vitro].
Luo Y; Zhang YD; Peng J; Yan HX; Xue D; Wu K; Zhou L; Hang SW; Zhao JF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 May; 25(5):437-9. PubMed ID: 19426602
[TBL] [Abstract][Full Text] [Related]
12. [Detection and comparison of transcriptional activities of tumor-specific survivin and alpha-fetoprotein promoters in human hepatocellular carcinoma cells].
Kuang G; Huang AL; Tang N
Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):440-2. PubMed ID: 15975279
[TBL] [Abstract][Full Text] [Related]
13. [Impact of AFP promoter on the expressions of GFP in tumor cells].
Mao CQ; Huang CZ; Yang SD; Zhao M; Fan YX; Xu F; Du F
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):495-8. PubMed ID: 12905870
[TBL] [Abstract][Full Text] [Related]
14. Recombinant attenuated Salmonella typhimurium carrying a plasmid co-expressing ENDO-VEGI151 and survivin siRNA inhibits the growth of breast cancer in vivo.
Li Z; Yin PH; Yang SS; Li QY; Chang T; Fang L; Shi LX; Fang GE
Mol Med Rep; 2013 Apr; 7(4):1215-22. PubMed ID: 23404494
[TBL] [Abstract][Full Text] [Related]
15. Small interfering RNA survivin and GRIM-19 co-expression salmonella plasmid inhibited the growth of laryngeal cancer cells in vitro and in vivo.
Wen LJ; Gao LF; Jin CS; Zhang HJ; Ji K; Yang JP; Zhao XJ; Wen MJ; Guan GF
Int J Clin Exp Pathol; 2013; 6(10):2071-81. PubMed ID: 24133585
[TBL] [Abstract][Full Text] [Related]
16. [Expression and localization of strong epitope hAFP(542-550); on eukaryotic cytoplasmic membrane].
Yang DY; Li CH; Lan F; Zhang YQ; Lu FG; Yang ZR; Huang LQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Jul; 25(7):592-5, 599. PubMed ID: 19737475
[TBL] [Abstract][Full Text] [Related]
17. [Functions of NET-1 gene in skin squamous cell carcinoma cell line (A431): a siRNA study].
Chen L; Wang JL; Li H; Qin J; Wu YY
Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):691-6. PubMed ID: 20078975
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy with biosynthetic nanoscale peptide Cecropin A driven by the survivin promoter for hepatocarcinoma cells.
Gong L; Qu L; Li Z; Li Q; Xu H; Shen P; Pang L; Gong R; Ji G; Si J
J Biomed Nanotechnol; 2014 Jul; 10(7):1391-9. PubMed ID: 24804559
[TBL] [Abstract][Full Text] [Related]
19. [Effect of survivin antisense mRNA transfection on the growth and chemotherapy sensitivity of lymphoma cells].
Gu X; Lin HL; Shao JY; Zhang M; Zhu YK; Liang HZ; Ma YH
Zhonghua Bing Li Xue Za Zhi; 2005 Nov; 34(11):737-41. PubMed ID: 16536320
[TBL] [Abstract][Full Text] [Related]
20. Construction of a targeting adenoviral vector carrying AFP promoter for expressing EGFP gene in AFP-producing hepatocarcinoma cell.
Shi YJ; Gong JP; Liu CA; Li XH; Mei Y; Mi C; Huo YY
World J Gastroenterol; 2004 Jan; 10(2):186-9. PubMed ID: 14716819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
